Global Modified Live Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Modified Live Vaccine market size was valued at US$ 552 million in 2025 and is forecast to a readjusted size of US$ 826 million by 2032 with a CAGR of 6.8% during review period.
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
This report is a detailed and comprehensive analysis for global Modified Live Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Modified Live Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Modified Live Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
This report is a detailed and comprehensive analysis for global Modified Live Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Modified Live Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Modified Live Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Modified Live Vaccine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Modified Live Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monovalent Live Attenuated Vaccines
- Multivalent Live Attenuated Vaccines
- Combination Live Attenuated Vaccines
- Viral Live Attenuated Vaccines
- Bacterial Live Attenuated Vaccines
- Parasitic Live Attenuated Vaccines
- Livestock
- Poultry
- Companion Animals
- Others
- Zoetis
- Ceva Sant? Animale
- Boehringer Ingelheim Animal Health
- MSD Animal Health
- Virbac
- HIPRA
- Vetoquinol
- Phibro Animal Health
- IDT Biologika
- Vaxxinova
- KBNP Inc.
- China Pharmaceutical Group Animal Health Co., Ltd.
- Jinyu Bio-technology Co., Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Modified Live Vaccine product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Modified Live Vaccine, with price, sales quantity, revenue, and global market share of Modified Live Vaccine from 2021 to 2026.
- Chapter 3, the Modified Live Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Modified Live Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Modified Live Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Modified Live Vaccine.
- Chapter 14 and 15, to describe Modified Live Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Modified Live Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Monovalent Live Attenuated Vaccines
1.3.3 Multivalent Live Attenuated Vaccines
1.3.4 Combination Live Attenuated Vaccines
1.4 Market Analysis by Pathogen
1.4.1 Overview: Global Modified Live Vaccine Consumption Value by Pathogen: 2021 Versus 2025 Versus 2032
1.4.2 Viral Live Attenuated Vaccines
1.4.3 Bacterial Live Attenuated Vaccines
1.4.4 Parasitic Live Attenuated Vaccines
1.5 Market Analysis by Application
1.5.1 Overview: Global Modified Live Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Livestock
1.5.3 Poultry
1.5.4 Companion Animals
1.5.5 Others
1.6 Global Modified Live Vaccine Market Size & Forecast
1.6.1 Global Modified Live Vaccine Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Modified Live Vaccine Sales Quantity (2021-2032)
1.6.3 Global Modified Live Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Modified Live Vaccine Product and Services
2.1.4 Zoetis Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Zoetis Recent Developments/Updates
2.2 Ceva Sant? Animale
2.2.1 Ceva Sant? Animale Details
2.2.2 Ceva Sant? Animale Major Business
2.2.3 Ceva Sant? Animale Modified Live Vaccine Product and Services
2.2.4 Ceva Sant? Animale Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ceva Sant? Animale Recent Developments/Updates
2.3 Boehringer Ingelheim Animal Health
2.3.1 Boehringer Ingelheim Animal Health Details
2.3.2 Boehringer Ingelheim Animal Health Major Business
2.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
2.3.4 Boehringer Ingelheim Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
2.4 MSD Animal Health
2.4.1 MSD Animal Health Details
2.4.2 MSD Animal Health Major Business
2.4.3 MSD Animal Health Modified Live Vaccine Product and Services
2.4.4 MSD Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MSD Animal Health Recent Developments/Updates
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Modified Live Vaccine Product and Services
2.5.4 Virbac Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Virbac Recent Developments/Updates
2.6 HIPRA
2.6.1 HIPRA Details
2.6.2 HIPRA Major Business
2.6.3 HIPRA Modified Live Vaccine Product and Services
2.6.4 HIPRA Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 HIPRA Recent Developments/Updates
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Modified Live Vaccine Product and Services
2.7.4 Vetoquinol Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Vetoquinol Recent Developments/Updates
2.8 Phibro Animal Health
2.8.1 Phibro Animal Health Details
2.8.2 Phibro Animal Health Major Business
2.8.3 Phibro Animal Health Modified Live Vaccine Product and Services
2.8.4 Phibro Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Phibro Animal Health Recent Developments/Updates
2.9 IDT Biologika
2.9.1 IDT Biologika Details
2.9.2 IDT Biologika Major Business
2.9.3 IDT Biologika Modified Live Vaccine Product and Services
2.9.4 IDT Biologika Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 IDT Biologika Recent Developments/Updates
2.10 Vaxxinova
2.10.1 Vaxxinova Details
2.10.2 Vaxxinova Major Business
2.10.3 Vaxxinova Modified Live Vaccine Product and Services
2.10.4 Vaxxinova Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vaxxinova Recent Developments/Updates
2.11 KBNP Inc.
2.11.1 KBNP Inc. Details
2.11.2 KBNP Inc. Major Business
2.11.3 KBNP Inc. Modified Live Vaccine Product and Services
2.11.4 KBNP Inc. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 KBNP Inc. Recent Developments/Updates
2.12 China Pharmaceutical Group Animal Health Co., Ltd.
2.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Details
2.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Major Business
2.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
2.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
2.13 Jinyu Bio-technology Co., Ltd.
2.13.1 Jinyu Bio-technology Co., Ltd. Details
2.13.2 Jinyu Bio-technology Co., Ltd. Major Business
2.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
2.13.4 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODIFIED LIVE VACCINE BY MANUFACTURER
3.1 Global Modified Live Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Modified Live Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Modified Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Modified Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Modified Live Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Modified Live Vaccine Manufacturer Market Share in 2025
3.5 Modified Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Modified Live Vaccine Market: Region Footprint
3.5.2 Modified Live Vaccine Market: Company Product Type Footprint
3.5.3 Modified Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Modified Live Vaccine Market Size by Region
4.1.1 Global Modified Live Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Modified Live Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Modified Live Vaccine Average Price by Region (2021-2032)
4.2 North America Modified Live Vaccine Consumption Value (2021-2032)
4.3 Europe Modified Live Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Modified Live Vaccine Consumption Value (2021-2032)
4.5 South America Modified Live Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Modified Live Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Modified Live Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Modified Live Vaccine Consumption Value by Type (2021-2032)
5.3 Global Modified Live Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Modified Live Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Modified Live Vaccine Consumption Value by Application (2021-2032)
6.3 Global Modified Live Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Modified Live Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Modified Live Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Modified Live Vaccine Market Size by Country
7.3.1 North America Modified Live Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Modified Live Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Modified Live Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Modified Live Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Modified Live Vaccine Market Size by Country
8.3.1 Europe Modified Live Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Modified Live Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Modified Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Modified Live Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Modified Live Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Modified Live Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Modified Live Vaccine Market Size by Country
10.3.1 South America Modified Live Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Modified Live Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Modified Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Modified Live Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Modified Live Vaccine Market Drivers
12.2 Modified Live Vaccine Market Restraints
12.3 Modified Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Modified Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Modified Live Vaccine
13.3 Modified Live Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Modified Live Vaccine Typical Distributors
14.3 Modified Live Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Modified Live Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Monovalent Live Attenuated Vaccines
1.3.3 Multivalent Live Attenuated Vaccines
1.3.4 Combination Live Attenuated Vaccines
1.4 Market Analysis by Pathogen
1.4.1 Overview: Global Modified Live Vaccine Consumption Value by Pathogen: 2021 Versus 2025 Versus 2032
1.4.2 Viral Live Attenuated Vaccines
1.4.3 Bacterial Live Attenuated Vaccines
1.4.4 Parasitic Live Attenuated Vaccines
1.5 Market Analysis by Application
1.5.1 Overview: Global Modified Live Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Livestock
1.5.3 Poultry
1.5.4 Companion Animals
1.5.5 Others
1.6 Global Modified Live Vaccine Market Size & Forecast
1.6.1 Global Modified Live Vaccine Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Modified Live Vaccine Sales Quantity (2021-2032)
1.6.3 Global Modified Live Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Modified Live Vaccine Product and Services
2.1.4 Zoetis Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Zoetis Recent Developments/Updates
2.2 Ceva Sant? Animale
2.2.1 Ceva Sant? Animale Details
2.2.2 Ceva Sant? Animale Major Business
2.2.3 Ceva Sant? Animale Modified Live Vaccine Product and Services
2.2.4 Ceva Sant? Animale Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ceva Sant? Animale Recent Developments/Updates
2.3 Boehringer Ingelheim Animal Health
2.3.1 Boehringer Ingelheim Animal Health Details
2.3.2 Boehringer Ingelheim Animal Health Major Business
2.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
2.3.4 Boehringer Ingelheim Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
2.4 MSD Animal Health
2.4.1 MSD Animal Health Details
2.4.2 MSD Animal Health Major Business
2.4.3 MSD Animal Health Modified Live Vaccine Product and Services
2.4.4 MSD Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MSD Animal Health Recent Developments/Updates
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Modified Live Vaccine Product and Services
2.5.4 Virbac Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Virbac Recent Developments/Updates
2.6 HIPRA
2.6.1 HIPRA Details
2.6.2 HIPRA Major Business
2.6.3 HIPRA Modified Live Vaccine Product and Services
2.6.4 HIPRA Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 HIPRA Recent Developments/Updates
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Modified Live Vaccine Product and Services
2.7.4 Vetoquinol Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Vetoquinol Recent Developments/Updates
2.8 Phibro Animal Health
2.8.1 Phibro Animal Health Details
2.8.2 Phibro Animal Health Major Business
2.8.3 Phibro Animal Health Modified Live Vaccine Product and Services
2.8.4 Phibro Animal Health Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Phibro Animal Health Recent Developments/Updates
2.9 IDT Biologika
2.9.1 IDT Biologika Details
2.9.2 IDT Biologika Major Business
2.9.3 IDT Biologika Modified Live Vaccine Product and Services
2.9.4 IDT Biologika Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 IDT Biologika Recent Developments/Updates
2.10 Vaxxinova
2.10.1 Vaxxinova Details
2.10.2 Vaxxinova Major Business
2.10.3 Vaxxinova Modified Live Vaccine Product and Services
2.10.4 Vaxxinova Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vaxxinova Recent Developments/Updates
2.11 KBNP Inc.
2.11.1 KBNP Inc. Details
2.11.2 KBNP Inc. Major Business
2.11.3 KBNP Inc. Modified Live Vaccine Product and Services
2.11.4 KBNP Inc. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 KBNP Inc. Recent Developments/Updates
2.12 China Pharmaceutical Group Animal Health Co., Ltd.
2.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Details
2.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Major Business
2.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
2.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
2.13 Jinyu Bio-technology Co., Ltd.
2.13.1 Jinyu Bio-technology Co., Ltd. Details
2.13.2 Jinyu Bio-technology Co., Ltd. Major Business
2.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
2.13.4 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MODIFIED LIVE VACCINE BY MANUFACTURER
3.1 Global Modified Live Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Modified Live Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global Modified Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Modified Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Modified Live Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 Modified Live Vaccine Manufacturer Market Share in 2025
3.5 Modified Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Modified Live Vaccine Market: Region Footprint
3.5.2 Modified Live Vaccine Market: Company Product Type Footprint
3.5.3 Modified Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Modified Live Vaccine Market Size by Region
4.1.1 Global Modified Live Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global Modified Live Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global Modified Live Vaccine Average Price by Region (2021-2032)
4.2 North America Modified Live Vaccine Consumption Value (2021-2032)
4.3 Europe Modified Live Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific Modified Live Vaccine Consumption Value (2021-2032)
4.5 South America Modified Live Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa Modified Live Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Modified Live Vaccine Sales Quantity by Type (2021-2032)
5.2 Global Modified Live Vaccine Consumption Value by Type (2021-2032)
5.3 Global Modified Live Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Modified Live Vaccine Sales Quantity by Application (2021-2032)
6.2 Global Modified Live Vaccine Consumption Value by Application (2021-2032)
6.3 Global Modified Live Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Modified Live Vaccine Sales Quantity by Type (2021-2032)
7.2 North America Modified Live Vaccine Sales Quantity by Application (2021-2032)
7.3 North America Modified Live Vaccine Market Size by Country
7.3.1 North America Modified Live Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America Modified Live Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Modified Live Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe Modified Live Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe Modified Live Vaccine Market Size by Country
8.3.1 Europe Modified Live Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe Modified Live Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Modified Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Modified Live Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Modified Live Vaccine Sales Quantity by Type (2021-2032)
10.2 South America Modified Live Vaccine Sales Quantity by Application (2021-2032)
10.3 South America Modified Live Vaccine Market Size by Country
10.3.1 South America Modified Live Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America Modified Live Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Modified Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Modified Live Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Modified Live Vaccine Market Drivers
12.2 Modified Live Vaccine Market Restraints
12.3 Modified Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Modified Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Modified Live Vaccine
13.3 Modified Live Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Modified Live Vaccine Typical Distributors
14.3 Modified Live Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Modified Live Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Modified Live Vaccine Consumption Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Table 3. Global Modified Live Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Zoetis Basic Information, Manufacturing Base and Competitors
Table 5. Zoetis Major Business
Table 6. Zoetis Modified Live Vaccine Product and Services
Table 7. Zoetis Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Zoetis Recent Developments/Updates
Table 9. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 10. Ceva Sant? Animale Major Business
Table 11. Ceva Sant? Animale Modified Live Vaccine Product and Services
Table 12. Ceva Sant? Animale Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Ceva Sant? Animale Recent Developments/Updates
Table 14. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 15. Boehringer Ingelheim Animal Health Major Business
Table 16. Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
Table 17. Boehringer Ingelheim Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 19. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 20. MSD Animal Health Major Business
Table 21. MSD Animal Health Modified Live Vaccine Product and Services
Table 22. MSD Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. MSD Animal Health Recent Developments/Updates
Table 24. Virbac Basic Information, Manufacturing Base and Competitors
Table 25. Virbac Major Business
Table 26. Virbac Modified Live Vaccine Product and Services
Table 27. Virbac Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Virbac Recent Developments/Updates
Table 29. HIPRA Basic Information, Manufacturing Base and Competitors
Table 30. HIPRA Major Business
Table 31. HIPRA Modified Live Vaccine Product and Services
Table 32. HIPRA Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. HIPRA Recent Developments/Updates
Table 34. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 35. Vetoquinol Major Business
Table 36. Vetoquinol Modified Live Vaccine Product and Services
Table 37. Vetoquinol Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Vetoquinol Recent Developments/Updates
Table 39. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 40. Phibro Animal Health Major Business
Table 41. Phibro Animal Health Modified Live Vaccine Product and Services
Table 42. Phibro Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Phibro Animal Health Recent Developments/Updates
Table 44. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 45. IDT Biologika Major Business
Table 46. IDT Biologika Modified Live Vaccine Product and Services
Table 47. IDT Biologika Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. IDT Biologika Recent Developments/Updates
Table 49. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 50. Vaxxinova Major Business
Table 51. Vaxxinova Modified Live Vaccine Product and Services
Table 52. Vaxxinova Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Vaxxinova Recent Developments/Updates
Table 54. KBNP Inc. Basic Information, Manufacturing Base and Competitors
Table 55. KBNP Inc. Major Business
Table 56. KBNP Inc. Modified Live Vaccine Product and Services
Table 57. KBNP Inc. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. KBNP Inc. Recent Developments/Updates
Table 59. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. China Pharmaceutical Group Animal Health Co., Ltd. Major Business
Table 61. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
Table 62. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
Table 64. Jinyu Bio-technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 65. Jinyu Bio-technology Co., Ltd. Major Business
Table 66. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
Table 67. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
Table 69. Global Modified Live Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 70. Global Modified Live Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 71. Global Modified Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 72. Market Position of Manufacturers in Modified Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 73. Head Office and Modified Live Vaccine Production Site of Key Manufacturer
Table 74. Modified Live Vaccine Market: Company Product Type Footprint
Table 75. Modified Live Vaccine Market: Company Product Application Footprint
Table 76. Modified Live Vaccine New Market Entrants and Barriers to Market Entry
Table 77. Modified Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 78. Global Modified Live Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 79. Global Modified Live Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 80. Global Modified Live Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 81. Global Modified Live Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 82. Global Modified Live Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 83. Global Modified Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 84. Global Modified Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 85. Global Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 86. Global Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 87. Global Modified Live Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Global Modified Live Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Global Modified Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 90. Global Modified Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 91. Global Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 92. Global Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 93. Global Modified Live Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 94. Global Modified Live Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 95. Global Modified Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 96. Global Modified Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 97. North America Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 98. North America Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 99. North America Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 100. North America Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 101. North America Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 102. North America Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 103. North America Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 104. North America Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Europe Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 106. Europe Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 107. Europe Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 108. Europe Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 109. Europe Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 110. Europe Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 111. Europe Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Europe Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 114. Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 115. Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 116. Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 117. Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 118. Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 119. Asia-Pacific Modified Live Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 120. Asia-Pacific Modified Live Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 121. South America Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 122. South America Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 123. South America Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 124. South America Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 125. South America Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 126. South America Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 127. South America Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 130. Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 131. Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 132. Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 133. Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 134. Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 135. Middle East & Africa Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Middle East & Africa Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Modified Live Vaccine Raw Material
Table 138. Key Manufacturers of Modified Live Vaccine Raw Materials
Table 139. Modified Live Vaccine Typical Distributors
Table 140. Modified Live Vaccine Typical Customers
Table 1. Global Modified Live Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Modified Live Vaccine Consumption Value by Pathogen, (USD Million), 2021 & 2025 & 2032
Table 3. Global Modified Live Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Zoetis Basic Information, Manufacturing Base and Competitors
Table 5. Zoetis Major Business
Table 6. Zoetis Modified Live Vaccine Product and Services
Table 7. Zoetis Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Zoetis Recent Developments/Updates
Table 9. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 10. Ceva Sant? Animale Major Business
Table 11. Ceva Sant? Animale Modified Live Vaccine Product and Services
Table 12. Ceva Sant? Animale Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Ceva Sant? Animale Recent Developments/Updates
Table 14. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 15. Boehringer Ingelheim Animal Health Major Business
Table 16. Boehringer Ingelheim Animal Health Modified Live Vaccine Product and Services
Table 17. Boehringer Ingelheim Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 19. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 20. MSD Animal Health Major Business
Table 21. MSD Animal Health Modified Live Vaccine Product and Services
Table 22. MSD Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. MSD Animal Health Recent Developments/Updates
Table 24. Virbac Basic Information, Manufacturing Base and Competitors
Table 25. Virbac Major Business
Table 26. Virbac Modified Live Vaccine Product and Services
Table 27. Virbac Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Virbac Recent Developments/Updates
Table 29. HIPRA Basic Information, Manufacturing Base and Competitors
Table 30. HIPRA Major Business
Table 31. HIPRA Modified Live Vaccine Product and Services
Table 32. HIPRA Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. HIPRA Recent Developments/Updates
Table 34. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 35. Vetoquinol Major Business
Table 36. Vetoquinol Modified Live Vaccine Product and Services
Table 37. Vetoquinol Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Vetoquinol Recent Developments/Updates
Table 39. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 40. Phibro Animal Health Major Business
Table 41. Phibro Animal Health Modified Live Vaccine Product and Services
Table 42. Phibro Animal Health Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Phibro Animal Health Recent Developments/Updates
Table 44. IDT Biologika Basic Information, Manufacturing Base and Competitors
Table 45. IDT Biologika Major Business
Table 46. IDT Biologika Modified Live Vaccine Product and Services
Table 47. IDT Biologika Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. IDT Biologika Recent Developments/Updates
Table 49. Vaxxinova Basic Information, Manufacturing Base and Competitors
Table 50. Vaxxinova Major Business
Table 51. Vaxxinova Modified Live Vaccine Product and Services
Table 52. Vaxxinova Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Vaxxinova Recent Developments/Updates
Table 54. KBNP Inc. Basic Information, Manufacturing Base and Competitors
Table 55. KBNP Inc. Major Business
Table 56. KBNP Inc. Modified Live Vaccine Product and Services
Table 57. KBNP Inc. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. KBNP Inc. Recent Developments/Updates
Table 59. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. China Pharmaceutical Group Animal Health Co., Ltd. Major Business
Table 61. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product and Services
Table 62. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. China Pharmaceutical Group Animal Health Co., Ltd. Recent Developments/Updates
Table 64. Jinyu Bio-technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 65. Jinyu Bio-technology Co., Ltd. Major Business
Table 66. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product and Services
Table 67. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Jinyu Bio-technology Co., Ltd. Recent Developments/Updates
Table 69. Global Modified Live Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 70. Global Modified Live Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 71. Global Modified Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 72. Market Position of Manufacturers in Modified Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 73. Head Office and Modified Live Vaccine Production Site of Key Manufacturer
Table 74. Modified Live Vaccine Market: Company Product Type Footprint
Table 75. Modified Live Vaccine Market: Company Product Application Footprint
Table 76. Modified Live Vaccine New Market Entrants and Barriers to Market Entry
Table 77. Modified Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 78. Global Modified Live Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 79. Global Modified Live Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 80. Global Modified Live Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 81. Global Modified Live Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 82. Global Modified Live Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 83. Global Modified Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 84. Global Modified Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 85. Global Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 86. Global Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 87. Global Modified Live Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Global Modified Live Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Global Modified Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 90. Global Modified Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 91. Global Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 92. Global Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 93. Global Modified Live Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 94. Global Modified Live Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 95. Global Modified Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 96. Global Modified Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 97. North America Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 98. North America Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 99. North America Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 100. North America Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 101. North America Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 102. North America Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 103. North America Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 104. North America Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Europe Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 106. Europe Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 107. Europe Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 108. Europe Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 109. Europe Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 110. Europe Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 111. Europe Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Europe Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 114. Asia-Pacific Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 115. Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 116. Asia-Pacific Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 117. Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 118. Asia-Pacific Modified Live Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 119. Asia-Pacific Modified Live Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 120. Asia-Pacific Modified Live Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 121. South America Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 122. South America Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 123. South America Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 124. South America Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 125. South America Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 126. South America Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 127. South America Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 130. Middle East & Africa Modified Live Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 131. Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 132. Middle East & Africa Modified Live Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 133. Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 134. Middle East & Africa Modified Live Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 135. Middle East & Africa Modified Live Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Middle East & Africa Modified Live Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Modified Live Vaccine Raw Material
Table 138. Key Manufacturers of Modified Live Vaccine Raw Materials
Table 139. Modified Live Vaccine Typical Distributors
Table 140. Modified Live Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Modified Live Vaccine Picture
Figure 2. Global Modified Live Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Modified Live Vaccine Revenue Market Share by Type in 2025
Figure 4. Monovalent Live Attenuated Vaccines Examples
Figure 5. Multivalent Live Attenuated Vaccines Examples
Figure 6. Combination Live Attenuated Vaccines Examples
Figure 7. Global Modified Live Vaccine Revenue by Pathogen, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Modified Live Vaccine Revenue Market Share by Pathogen in 2025
Figure 9. Viral Live Attenuated Vaccines Examples
Figure 10. Bacterial Live Attenuated Vaccines Examples
Figure 11. Parasitic Live Attenuated Vaccines Examples
Figure 12. Global Modified Live Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Modified Live Vaccine Revenue Market Share by Application in 2025
Figure 14. Livestock Examples
Figure 15. Poultry Examples
Figure 16. Companion Animals Examples
Figure 17. Others Examples
Figure 18. Global Modified Live Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Modified Live Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Modified Live Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 21. Global Modified Live Vaccine Price (2021-2032) & (US$/Dose)
Figure 22. Global Modified Live Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Modified Live Vaccine Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Modified Live Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Modified Live Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Modified Live Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Modified Live Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Modified Live Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Modified Live Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Modified Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 37. Global Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Modified Live Vaccine Revenue Market Share by Application (2021-2032)
Figure 39. Global Modified Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 40. North America Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 52. France Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Modified Live Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 60. China Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. India Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Modified Live Vaccine Market Drivers
Figure 81. Modified Live Vaccine Market Restraints
Figure 82. Modified Live Vaccine Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Modified Live Vaccine in 2025
Figure 85. Manufacturing Process Analysis of Modified Live Vaccine
Figure 86. Modified Live Vaccine Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Figure 1. Modified Live Vaccine Picture
Figure 2. Global Modified Live Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Modified Live Vaccine Revenue Market Share by Type in 2025
Figure 4. Monovalent Live Attenuated Vaccines Examples
Figure 5. Multivalent Live Attenuated Vaccines Examples
Figure 6. Combination Live Attenuated Vaccines Examples
Figure 7. Global Modified Live Vaccine Revenue by Pathogen, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Modified Live Vaccine Revenue Market Share by Pathogen in 2025
Figure 9. Viral Live Attenuated Vaccines Examples
Figure 10. Bacterial Live Attenuated Vaccines Examples
Figure 11. Parasitic Live Attenuated Vaccines Examples
Figure 12. Global Modified Live Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Modified Live Vaccine Revenue Market Share by Application in 2025
Figure 14. Livestock Examples
Figure 15. Poultry Examples
Figure 16. Companion Animals Examples
Figure 17. Others Examples
Figure 18. Global Modified Live Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Modified Live Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Modified Live Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 21. Global Modified Live Vaccine Price (2021-2032) & (US$/Dose)
Figure 22. Global Modified Live Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global Modified Live Vaccine Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of Modified Live Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 Modified Live Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 Modified Live Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 27. Global Modified Live Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global Modified Live Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 29. North America Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. Global Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global Modified Live Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 36. Global Modified Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 37. Global Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global Modified Live Vaccine Revenue Market Share by Application (2021-2032)
Figure 39. Global Modified Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 40. North America Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 52. France Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Modified Live Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific Modified Live Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 60. China Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. India Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Modified Live Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa Modified Live Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa Modified Live Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Modified Live Vaccine Market Drivers
Figure 81. Modified Live Vaccine Market Restraints
Figure 82. Modified Live Vaccine Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Modified Live Vaccine in 2025
Figure 85. Manufacturing Process Analysis of Modified Live Vaccine
Figure 86. Modified Live Vaccine Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
